1. Home
  2. SCLXW vs ACAAU Comparison

SCLXW vs ACAAU Comparison

Compare SCLXW & ACAAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLXW

Scilex Holding Company

HOLD

Current Price

$0.17

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

ACAAU

Averin Capital Acquisition Corp. Units

N/A

Current Price

$10.00

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLXW
ACAAU
Founded
N/A
N/A
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
SCLXW
ACAAU
Price
$0.17
$10.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.5K
3.7K
Earning Date
03-07-2025
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$55,152,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.02
N/A
52 Week Low
$0.04
$9.95
52 Week High
$0.64
$10.31

Technical Indicators

Market Signals
Indicator
SCLXW
ACAAU
Relative Strength Index (RSI) 52.21 44.77
Support Level $0.11 $9.99
Resistance Level $0.18 $10.13
Average True Range (ATR) 0.02 0.08
MACD -0.00 0.00
Stochastic Oscillator 51.11 0.00

Price Performance

Historical Comparison
SCLXW
ACAAU

About SCLXW Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About ACAAU Averin Capital Acquisition Corp. Units

Averin Capital Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: